Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa) Meeting Abstract


Authors: Wagner, A. J.; Riedel, R. F.; Van Tine, B. A.; Chugh, R.; Ganjoo, K. N.; Cranmer, L. D.; Pollack, S.; Sankhala, K. K.; Gordon, E. M.; Ravi, V.; Hornick, J. L.; Kwiatkowski, D. J.; Grigorian, B.; Desai, N.; Dickson, M. A.
Abstract Title: Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa)
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 598s
Language: English
ACCESSION: WOS:000442916008050
DOI: 10.1200/JCO.2018.36.15_suppl.TPS11589
PROVIDER: wos
Notes: Meeting Abstract : TPS11589 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neil B Desai
    36 Desai
  2. Mark Andrew Dickson
    170 Dickson